Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$12,537 | $4,464 | -$597 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 |
| Change in WC | $1,034 | $687 | $454 |
| Other Non-Cash | $9,449 | -$5,804 | $0 |
| Operating Cash Flow | -$2,055 | -$653 | -$143 |
| Investing Activities | – | – | – |
| PP&E Inv. | $0 | $0 | -$4,895 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $13,781 | $0 | $0 |
| Other Inv. Act. | $0 | $284,916 | $0 |
| Investing Cash Flow | $13,781 | $284,916 | -$4,895 |
| Financing Activities | – | – | – |
| Debt Repay. | $1,711 | $0 | -$253 |
| Stock Issued | $343 | $156 | $1,000 |
| Stock Repurch. | -$13,781 | -$284,916 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $4,105 |
| Financing Cash Flow | -$11,727 | -$284,760 | $4,853 |
| Forex Effect | -$0 | $0 | $0 |
| Net Chg. in Cash | $0 | -$497 | -$185 |
| Supplemental Information | – | – | – |
| Beg. Cash | $0 | $497 | $185 |
| End Cash | $0 | $0 | $0 |
| Free Cash Flow | -$2,055 | -$653 | -$5,038 |